Since April 2024, Dr. Sai Karan Vamsi Guda has incorporated CyPath® Lung into his practice: “For patients with small pulmonary nodules, six millimeters or larger, we utilize CyPath® Lung to be able to risk stratify them.” Want to learn how CyPath® Lung can support your practice? Reach out to admin@bioaffinitytech.com | bioAffinity Technologies

5.8K views · 160 reactions | A host of layer improvements are making their way into Affinity 2.1. Here’s a sneak peek! To try them out and have your say on new features and improvements before release, sign up for our beta program: affin.co/beta | Affinity | Facebook